Trick or Trade 2024Trick or Trade 2024🃏All Okidogi cards
Ask about Okidogi
Okidogi #111 Pokémon card from Trick or Trade 2024

Okidogi 111/30

Trick or Trade 2024

Find this card on eBay

Affiliate link · we may earn commission

Okidogi #111 from Trick or Trade 2024 currently trades at $0.25 raw, with PSA 10 copies reaching $56.18 — a 224.7x grade premium.
Current Prices (USD)
Ungraded
$0.25
PSA 7
$3.65
PSA 8
$3.65
PSA 9
$5.82
PSA 10
$56.18
ACE 10
BGS 10 Black
$365.00
CGC 10 Pristine
$29.99
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Okidogi 111/30 from Trick or Trade 2024 has a current raw market value of $0.25.

Current raw value
$0.25
PSA 9 value
$5.82
PSA 10 value
$56.18
View all cards from Trick or Trade 2024
Collector Intel
224.7x
Raw → PSA 10
High-risk grade
23.3x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 225x the raw price. The expected value accounts for the realistic probability.
$0
Buy Raw
~$25
Grading Fee
PSA Standard
$56
PSA 10 Value
+$31
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$623.3x raw
PSA 10$56224.7x raw

Frequently asked questions

How much is Okidogi #111 from Trick or Trade 2024 worth?+
Okidogi #111 from Trick or Trade 2024 is currently worth Raw: $0.25, PSA 9: $5.82, PSA 10: $56.18 based on recent sold listings. Prices update daily from real eBay sales.
Is Okidogi #111 worth grading?+
The PSA 10 price of $56.18 is 224.7× the raw price of $0.25. After a ~$25 grading fee, a PSA 10 result would net approximately $55.93 — assuming the card grades a 10.
Where do PokePrices Okidogi #111 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.